Heartburn/GERD News
-
FDA Requests Zantac Be Pulled From the Market
Six months after independent testing first raised the possibility that popular heartburn drug ranitidine (Zantac) might break down into the powerful carcinogen n-nitrosodimethylamine (NDMA), the FDA has asked for the removal of all ranitidine products from the market.
-
Could Heartburn Meds Lead to Drug-Resistant Germs?
The findings do not prove that PPIs -- which include popular brands such as Prilosec (omeprazole), Prevacid (lansoprazole) and Nexium (esomeprazole) -- are the cause, experts said. But they are the latest to raise safety questions about the top-selling prescription and over-the-counter medicines.
-
Surgery Helps Tough-to-Treat Acid Reflux
This surgery is done under general anesthesia with a laparoscope, a thin tube with a tiny video camera. The surgeon sews the top of the stomach around the esophagus.
-
Heartburn Drugs and Cancer: What Are the Risks?
FDA testing found the impurity in generic versions and in brand-name Zantac. Already, one major manufacturer has recalled its version of the drug, and another has ceased distribution.
-
Maker Halts Distribution of Generic Zantac Due to Possible Carcinogen
A distribution halt is not the same as a full recall, and it means that generic Zantac (ranitidine) remaining on store shelves can still be sold, CBS News reported.
-
Zantac Heartburn Drug May Contain Carcinogen: FDA
While preliminary tests found low levels of the nitrosamine impurity N-nitrosodimethylamine (NDMA) in some ranitidine products, the FDA said this does not mean patients taking the drugs should stop using them now.
-
Researchers Weigh Benefits, Risks of PPIs
PPIs, or proton pump inhibitors, are among the most common prescription drugs and are used to treat acid reflux, heartburn, indigestion, gastroesophageal reflux disease (GERD), and stomach ulcers.
-
Heartburn Drugs Again Tied to Fatal Risks
Research in recent years has linked long-term use of drugs called proton pump inhibitors (PPIs) to increased risks of various diseases and premature death. These latest findings point to the specific causes of death.
-
Chronic Heartburn Tied to Higher Odds for Head, Neck Cancers
New research suggests people with chronic acid reflux might have higher odds for even more dangerous foes -- head and neck cancers
-
Common Heartburn Meds Show Ties to Kidney Trouble
The medicines in question are called proton pump inhibitors (PPIs). They reduce stomach acid production and are among the most widely prescribed medications in the world.
-
Are Some Heartburn Meds Tied to Stomach Cancer?
Popping certain heartburn drugs like they're candy might up your odds for stomach cancer, new research suggests.
-
Popular Heartburn Drugs Don't Raise Risk of Alzheimer's: Study
Researchers say proton pump inhibitors like Nexium or Prilosec not linked to dementia
-
Popular Heartburn Drugs May Boost Death Risk: Study
Popular heartburn drugs known as proton pump inhibitors may raise the chance of death, new research shows.
-
Are Heartburn Meds and Superbug Infections Linked?
Recurring bouts of C. difficile were more common in those who took drugs that lower stomach acid
-
Heartburn Drugs May Raise Stomach Infection Risk
Suggests long-term use of acid suppressors might open door to C. difficile and Campylobacter bacteria
-
Could Common Heartburn Drugs Up Stroke Risk?
Researchers concerned about high doses of meds like Nexium and Prilosec
-
Research Evaluates Possible Link to PPI Risks
Research Evaluates Possible Link to PPI Risks
-
How Popular Heartburn Drug Might Harm Arteries
Prior research has also raised concerns about Nexium and heart health
-
Common Heartburn Drugs Linked to Kidney Disease
But finding can't show whether drugs are directly responsible
-
Could a Low-Risk Surgery Help Chronic Heartburn?
Death rate from procedure lower than previously reported, study finds
-
Heartburn Meds Linked to Chronic Kidney Disease
While study can't prove cause-and-effect, increasing damage seen as dose rises
-
Heartburn Drugs Tied to Higher Kidney Disease Risk
But studies weren't designed to prove proton pump inhibitors are responsible for the increase
-
Popular Heartburn Meds Linked to Higher Risk of Heart Attack
But don't stop taking proton pump inhibitors based on this study, expert says
-
FDA OKs First Generic Version of Heartburn Drug Nexium
The proton pump inhibitor reduces amount of acid in the stomach
-
Could Popular Heartburn Drugs Upset Your 'Good' Gut Bugs?
Study suggests class of meds upset healthy balance of bacteria in the gut
Pagination